A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT02631577 · COMPLETED
Trial details
- NCT number
- NCT02631577
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-31
- Primary completion
- 2018-10-23
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.